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Mitochondrial inner membraneVoltage-dependent anion channel (VDAC) is an abundant mitochondrial outer membrane protein. In mammals,
three VDAC isoforms have been characterized. We have previously reported alterations in the function of
mitochondriawhenassessed in situ in differentmuscle types inVDAC1deﬁcientmice (Anﬂous et al., 2001). In the
present report we extend the study to VDAC3 deﬁcient muscles and measure the respiratory enzyme activity in
both VDAC1 and VDAC3 deﬁcient muscles. While in the heart the absence of VDAC3 causes a decrease in the
apparent afﬁnity of in situmitochondria for ADP, in the gastrocnemius, a mixed glycolytic/oxidative muscle, the
afﬁnity of in situ mitochondria for ADP remains unchanged. The absence of VDAC1 causes multiple defects in
respiratory complex activities in both types of muscle. However, in VDAC3 deﬁcient mice the defect is restricted
to the heart and only to complex IV. These functional alterations correlate with structural aberrations of
mitochondria. These results demonstrate that, unlike VDAC1, there ismuscle-type speciﬁcity for VDAC3 function
and therefore in vivo these two isoforms may fulﬁll different physiologic functions.e; MIM, mitochondrial inner
AC, voltage-dependent anion
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Many biochemical reactions in cells depend on a tightly controlled
ratio of ATP to ADP for their execution [1]. In oxidative tissues, this
ratio is preserved by regulatory mechanisms that couple the rate of
ATP consumption in the cell to the rate of ATP production by oxidative
phosphorylation in mitochondria [2]. The mitochondrial outer
membrane (MOM), as the boundary structure for mitochondria,
plays a regulatory role by integrating sites of ATP consumption and
production. Indeed, it has been demonstrated that, in vivo, the MOM
dynamically separates the intermembrane space from the extrami-
tochondrial space, leading to ADP compartmentation in the mito-
chondrial intermembrane space [3]. This was further demonstrated by
studies on permeabilized heart and skeletal muscle ﬁbers that have
shown that the MOM participates in the regulation of mitochondrial
respiration in vivo [4–7]. By analyzing heart skinned ﬁbers during the
ﬁrst 6 weeks of life, Tiivel et al. [8] reported a gradual decrease in the
apparent afﬁnity of mitochondria for ADP (Km(ADP)). This suggests a
developmental mechanism that increasingly limits the access of
cytoplasmic ADP to mitochondria. The communication between the
extra-mitochondrial domain and the intermembrane space is con-ferred by the voltage-dependent anion channels (VDACs). VDACs, also
known asmitochondrial porins, are small proteins of theMOMand are
the main pathway for the transport of metabolites. Rostovtseva and
Colombini [9] were the ﬁrst to provide evidence that VDACs mediate
the ﬂux of ATP. Being at the interface between mitochondria and the
cytosol, VDAC regulation potentially deﬁnes in which direction
mitochondria will go: respiration and viability or apoptosis and cell
death (reviewed in [10]). Indeed, it has been reported that a disruption
in ATP/ADP exchange across theMOMupon growth factor withdrawal
and induction of apoptosis correlates with the changes in conductance
properties that accompany closure of VDACs, suggesting that restric-
tion of ﬂux across the channel is an important trigger for the induction
of apoptosis. Based upon these observations, it has been proposed that
VDACs can control coupled respiration and cell survival [11].
The fact that VDACs interact with kinases and the adenine
nucleotide translocase (ANT) in important mitochondrial structures
such as special contact sites and megachannels, underlines its
regulatory role in mitochondrial energy metabolism [12,13]. A kinase
that functionally interacts with VDAC is creatine kinase. The creatine
kinase system, along with the glycolytic and adenylate kinase
pathways, plays a key role in the energy metabolism of cells with
intermittently high and ﬂuctuating energy requirements, such as
cardiac and skeletal muscle and neural tissue [14,15]. A primary
function of the creatine kinase system in cardiac and oxidative
skeletal muscle is the effective channeling of mitochondrial ATP
across the intermembrane space to the myoﬁbrils where it is
consumed in the contraction cycle. By being functionally coupled to
respiration, the mitochondrial isoform of creatine kinase (mi-CK)
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counterpart in the cytosol, plays a key role for the transfer of energy in
cardiac and oxidative skeletal muscle [4,5]. Accordingly, a decrease in
the apparent Km(ADP) has been reported in mouse mi-CK knock-out
muscles [16]. It is believed that this functional coupling increases the
ADP concentration close to the ANT and compensates for the barrier to
ADP diffusion exerted by theMOM. It has been suggested that creatine
diffuses through VDACs to reach mi-CK located in the mitochondrial
intermembrane space [17].
In higher eukaryotes, three VDAC isoforms have been character-
ized: VDAC1, VDAC2 and VDAC3 [18–24]. The three isoforms are
encoded by three separate genes [25,26]. Although VDACs are highly
conserved across species, the speciﬁc function of each isoform
remains poorly understood. VDAC1 and VDAC3 deﬁcient mice have
been successfully generated [27–29]. Despite a partial in utero
lethality, VDAC deﬁcient mice are viable and therefore provide an
opportunity to study the role(s) of VDACs in cellular metabolism in
intact organisms (reviewed in Craigen and Graham, 2008) [30]. We
have previously reported an alteration in the MOM permeability for
ADP in different muscle types in the absence of VDAC1. However, the
functional coupling of mi-CK to respiration remains intact in the
absence of VDAC1 [27]. To test the hypothesis that different VDAC
isoforms fulﬁll different roles in vivo and function in a tissue-speciﬁc
fashion, VDAC3 deﬁcient mice were used to measure the functional
properties of mitochondria in situ in two types of striated muscle, the
heart and the gastrocnemius, a mixed glycolytic/oxidative skeletal
muscle. We also measured the impact of the absence of VDAC1 and
VDAC3 on the activity of the respiratory enzyme complexes. We
report alterations of the mitochondrial structure and the permeability
of the MOM for ADP in VDAC3 deﬁcient heart but not VDAC3 deﬁcient
gastrocnemius. We also report a partial defect of the respiratory
enzyme activities in both types of muscle in VDAC1 deﬁcient mice.
However in VDAC3 deﬁcient mice, there is a single respiratory chain
defect that is restricted to the heart. Together, these data support the
hypothesis that, in vivo, VDAC1 and VDAC3 fulﬁll different functions.
2. Materials and methods
2.1. Animals
Unless otherwise indicated, wild type control and VDAC3 deﬁcient
(vdac3−/−) mice studied were on an inbred 129SvEv background. In
each set of experiments, at least ﬁve littermates wild type control
and vdac3−/− mice were used. Mice were ~8 months of age. The
genotypes of the mice were determined by PCR, as previously
described (27–29). All animal experiments conformed to Baylor
College of Medicine IACUC Guidelines for the care of rodents.
2.2. In situ mitochondrial respiratory studies
Mice were anesthetized by intraperitoneal injection of Urethane
(0.1 mg/30 g wet weigh). The hearts were quickly removed and
placed in a cooled, well oxygenated (95% O2+5% CO2) 1× PBS
solution without calcium (Amersham). Heart and gastrocnemius
skinned ﬁbers were prepared as previously described [27,31]. Rates of
oxygen consumption were assessed using an oxygraph (Biological
Monitor, YSI MODEL 5300) and a Clark electrode (Oxygen probe, YSI
5331) and recorded by a MacLab/200 system (AD Instruments). The
ADP-stimulated respiration above basal oxygen consumption were
plotted by using a GraphPad PRIZM program, version 2.0C in order to
determine the apparent Km(ADP) and the calculated rate of oxygen
consumption in the presence of maximal ADP concentration (Vmax)
[27]. The Km is termed apparent because the exact concentration of
ADP in the mitochondrial intermembrane space is not known. The
functional coupling of mi-CK to respiration was assessed in the
presence of 25 mM creatine. At the end of the experiments, the ﬁberswere removed from the respiration buffer, put on aluminum paper,
dried on a heating plate and weighed. Rate of respiration is given in
μmoles of oxygen/min/g dry weigh.
2.3. Electron microscopy
Samples of heart and gastrocnemius muscles from wild type
control and vdac3−/− mice were processed and examined by a
transmission electron microscopy as described previously [27].
2.4. Western blotting
We used afﬁnity puriﬁed rabbit polyclonal antibody speciﬁc for
VDAC1 (kindly provided by Dr. M. Colombini) and a chicken
polyclonal antibody speciﬁc for VDAC2 (similarly generated as
described in [32]) to quantify the amount of the corresponding
VDAC isoforms in vdac3−/− muscles. To detect VDAC3 in wild type
samples we used an afﬁnity puriﬁed chicken polyclonal antibody [32].
An actin-speciﬁc polyclonal antibody (Sigma) was used as a loading
control. For COXIV detection we used a monoclonal antibody
(Molecular Probes) and cytochrome c as loading control (Santa Cruz
Biotechnology). Heart and gastrocnemius muscles from wild type
control and vdac3−/− mice were homogenized by a polytron in a
buffer containing: Hepes 5 mM (pH 8.0), EGTA 1 mM, DTT 1 mM and
triton 0.1%. Antiprotease cocktail (1×) (P8340, Sigma) and phenyl-
methylsulfonyl (1 mM) were added to the buffer. The homogenates
were centrifuged at 550g, 5 °C for 5 min. 30 μg of total protein from
the supernatant was separated using a 12% Tris/HCl ready polyacryl-
amide-gel (Bio-Rad) and transferred to polyvinylidene diﬂuoride
membrane (Roche Molecular Biochemicals) using a Bio-Rad Trans-
Blot system. The membranes were blocked, incubated and developed
as described previously [33]. Protein concentrations were determined
with the BCA protein assay reagent (PIERCE), using BSA as standard.
2.5. Respiratory chain enzyme activities
Fresh heart and gastrocnemius muscles were homogenized to a
ﬁnal concentration of 10% with a Dounce glass-Teﬂon homogenizer.
The homogenates were prepared in sucrose buffer (Sucrose 150 mM,
EDTA 2 mM and Tris–HCl 100 mM, pH 7.45) and centrifuged at 550g,
5 °C for 20 min [34]. The assay was carried out in the supernatant at
30 °C using a temperature-controlled spectrophotometer (Pharmacia,
Biotech). The activities of complex I (NADH dehydrogenase), complex
II (succinate dehydrogenase), complex I+III (NADH:cytochrome c
oxidoreductase), complex II+III (succinate :cytochrome c reductase)
and complex IV (cytochrome c oxidase) were assayed using different
electron acceptors/donors. The activities of complex I+III and II+III
weremeasured by following the reduction of cytochrome c at 550 nm,
of complex I by following the oxidation of NADH at 340 nm, of
complex II by following the reduction of 2,6-dichloroindophenol
(DCIP) at 600 nm and of complex IV by following the oxidation of
reduced cytochrome c at 550 nm [35,36]. Citrate synthase activity was
measured to adjust enzymatic activities for mitochondrial content, as
previously described [37].
2.6. Statistical analysis
A two-tailed, unpaired t test was used to compare the data. The
level of signiﬁcance was set at pb0.05.
3. Results
3.1. In situ mitochondrial respiratory studies
VDAC is a major protein in the MOM. To test the hypothesis that
the different VDAC isoforms fulﬁll different functions within different
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in situ properties of mitochondria in the absence of VDAC3. In the
cardiac ﬁbers, we observed that the absence of VDAC3 results in an
increase of the apparent Km(ADP), reﬂecting a decrease in the afﬁnity
of mitochondria for ADP (Fig. 1A). In the presence of 25 mM creatine,
there is a decrease in the apparent Km(ADP) in both wild type and
vdac3−/− cardiac ﬁbers, consistent with the maintenance of the
creatine effect in the mutant ﬁbers (Fig. 1A). Vmax (respiration in the
presence of maximal ADP concentration) remains statistically
unchanged from the control, both in the absence and presence of
creatine (Fig. 1B). We used the gastrocnemius to address whether
VDAC3 fulﬁlls a different function in a different muscle type. In
contrast to the difference in the apparent Km(ADP) observed in VDAC3
deﬁcient cardiac ﬁbers, the absence of VDAC3 has no signiﬁcant effect
on the apparent Km(ADP) in gastrocnemius ﬁbers (Fig. 1C). Likewise,
Vmax remains statistically undistinguishable from the control (Fig. 1D).
3.2. Electron microscopy
To determine if the alterations in mitochondrial function are
associated with mitochondrial structural alterations, electron micros-
copy was used to examine the morphology of mitochondria in
both muscle types from wild type control and vdac3−/− mice. The
intermyoﬁbrillar mitochondria from vdac3−/− heart appear enlarged
with irregular cristae, with an appearance reminiscent of ﬁngerprints
(Fig. 2A and B). While in wild type heart, an average of two to three
mitochondria span two sarcomere units (indicated by asterisk in
Fig. 2A), in the VDAC3 deﬁcient heart, on average one mitochondrion
spans one sarcomere unit and even may span two sarcomere units
(indicated by head arrow in Fig. 2B). This enlargement of mitochon-
dria in the absence of VDAC3 is similar to that seen with vdac1−/−
mice, suggestive of a similar underlying mechanism. In the vdac3−/−
gastrocnemius, the mitochondria appear indistinguishable from the
wild type control sample in both intermyoﬁbrillar and subsarcolem-
mal populations (Fig. 2C, D, E and F).0
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Fig. 1. Functional properties of mitochondria. The in situ afﬁnity of mitochondria for ADP
control (black bar) and vdac3−/− (white bar) heart (A) and gastrocnemius (C) in the absence
the maximal ADP concentration (Vmax) was determined in ﬁbers prepared from wild type
absence (w/o) and presence of 25 mM creatine. Values are expressed in μmoles of oxygen/3.3. VDAC protein quantitation
We used western blot analysis to determine whether the absence
of VDAC3 has an impact on the amount of the remaining isoforms. The
amounts of VDAC1 and VDAC2 in themutant heart and gastrocnemius
remain indistinguishable from the control muscles (Fig. 3). Therefore,
the effects described reﬂect the absence of VDAC3 and are not due to
an alteration in the amount of the remaining VDAC isoforms.
3.4. Respiratory chain complex activities
As a component of the MOM, the absence of VDACmay potentially
inﬂuence the respiratory chain activity in two ways: by restricting the
access of substrates to the respiratory chain or by disturbing the
assembly or structure of the complexes, which in turn may affect
their functions. We determined spectrophotometrically the activity
of different respiratory complex activities in the heart and the
gastrocnemius from vdac1−/− and vdac3−/− mice. We observed
statistically signiﬁcant reductions in complex I+III, II+III and IV
activities in vdac1−/− muscles (Fig. 4A and B). Whereas vdac1−/−
heart does not exhibit any defect in complex I and II activities, there is
a defect in complex II activity in the gastrocnemius of vdac1−/−mice.
Complex I activity was not determined for vdac1−/− gastrocnemius.
For vdac3−/− mice, the respiratory chain defect is restricted to
complex IV and is only observed in the heart (Fig. 4A and B).
4. Discussion
In this report we have shown that while the absence of VDAC3 in
mice results in altered functional and structural properties of in situ
mitochondria in cardiac ﬁbers, mitochondria in the mixed muscle
gastrocnemius remain indistinguishable from control mitochondria.
We have previously reported that the absence of VDAC1 causes an
increase in the apparent Km(ADP) as well as an alteration in the
structure of mitochondria in both cardiac and gastrocnemius ﬁbers;B
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Fig. 2. Electron microscopy images of muscles. Heart and gastrocnemius muscles were dissected from wild type and vdac3−/−mice and mounted for electron microscopy analysis.
A and B show intermyoﬁbrillar mitochondria from wild type and vdac3−/− heart respectively. The head arrows indicate one mitochondrion that spans two sarcomere units. The
asterisks indicate an average of mitochondria within two sarcomere units. C and D show intermyoﬁbrillar mitochondria from wild type and vdac3−/− gastrocnemius respectively.
E and F show subsarcolemmal mitochondria from wild type and vdac3−/− gastrocnemius respectively. Magniﬁcation ×2000 (A) and (B), ×6000 (C), (D), (E) and (F).
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Fig. 4. Respiratory enzyme activities. The activities of complex I, II, I+III, II+III and IV
were determined and normalized to citrate synthase activity for mitochondrial content.
The normalized activity in wild type control was taken as 100% and the normalized
activity in the mutant muscles was calculated as a percent of the wild type control.
(A) Normalized respiratory enzyme activity in the heart. (B) Normalized respiratory
enzyme activity in the gastrocnemius. The black bar represents wild type muscle, the
white bar represents vdac1−/− muscle and the gray bar represents vdac3−/− muscle.
The error bars refer to SEM. *pb0.05 vs. wild type, **pb0.01 vs. wild type, ***pb0.001 vs.
wild type.
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function. Recently, at a more integrated level, we reported impaired
glucose tolerance with reduced mitochondria-bound hexokinase
activity in VDAC1 deﬁcient mice but not in VDAC3 deﬁcient mice
[33], further supporting the hypothesis that, in vivo, VDAC1 and
VDAC3 fulﬁll different physiologic functions.
4.1. Muscle type speciﬁcity for VDAC3 function
Fundamental differences between the oxidative and glycolytic
striated muscles have previously been reported [38]. These differ-
ences also include the organization of the CK system as well as the
permeability of the MOM for ADP [16,17,27,39]. Being the main
pathway in the MOM for small metabolites, it is believed that VDACs
regulate the permeability of the MOM and the functional coupling of
mi-CK to respiration. Similar to VDAC1, while VDAC3 is involved in
the exchange of ADP in cardiac muscle, its involvement in the creatine
effect on respiration remains questionable. This raises the possibility
that VDAC2 may be the isoform involved in the exchange of creatine
across the MOM. Since VDAC2 deﬁciency appears to be lethal to the
mouse [40], addressing this question depends upon the generation of
a conditional deletion of VDAC2 in muscles. In the gastrocnemius,
VDAC3 may fulﬁll a different function since we did not detect any
alteration in the apparent Km(ADP) between control and mutant ﬁbers.
The results of western blotting favor this hypothesis since there is no
variation in the amount of VDAC1 or VDAC2 in the absence of VDAC3
that would reﬂect a speciﬁc compensatory upregulation of theseisoforms. On the other hand, it has been reported that tubulin binds to
VDAC and regulates mitochondrial respiration [41]. More recently,
Saks et al. suggested that VDAC and tubulin are part of a supercomplex
that includes mi-CK and the ATP synthasome [42]. This supercomplex
assures continuous recycling of adenine nucleotides between mito-
chondria and cytoplasm. Although it is not known if VDAC3 interacts
with tubulin, one can speculate that the difference in the mitochon-
drial afﬁnity for ADP between cardiac muscle and the gastrocnemius
may be due to a muscle type speciﬁcity in the interaction of VDAC3
with tubulin.
4.2. The organization of the mitochondrial network is intact in the
absence of VDAC3
The functional alterations of mitochondria in vdac3−/− heart are
consistent with altered ultrastructure observed by electron micros-
copy. Their relatively increased size suggests alterations in mitochon-
drial fusion/ﬁssion processes. Since it has been reported that VDAC is
the binding site for microtubules [41,43], one would expect altera-
tions in the organization of the mitochondrial network in VDAC
deﬁcient muscles. Indeed, it was recently shown that the cytoskeleton
may play a role in the organization of mitochondrial networks and
their incorporation into functional complexes with the sarcomere and
sarcoplasmic reticulum [44]. Upon brief proteolytic treatment with
trypsin, the authors demonstrated that disorganization of microtu-
bular and plectin networks together with the mitochondrial network
occur. Interestingly, mitochondria in vdac3−/− heart preserve their
organization within the myoﬁbrils suggesting that the structural
interaction between the cytoskeletal elements and mitochondria is
preserved in the absence of VDAC3. The same observation has
previously been made in VDAC1 deﬁcient muscles [27]. These results
suggest a redundancy among VDAC isoforms in their structural
interaction with the cytoskeleton and/or that VDAC2 is the main
isoform interacting with the microtubular network.
4.3. Complex IV deﬁciency in VDAC3 deﬁcient heart
Structural alteration of mitochondria is a hallmark of patients with
a variety of mitochondrial diseases [45,46]. Despite extensive studies
of the function and structure of mitochondria, much of the underlying
pathogenic processes of mitochondrial diseases remain poorly
understood (reviewed in [47]). A large number of mitochondrial
diseases originate from respiratory chain dysfunction. The demon-
stration that loss of a MOM channel leads to a variety of respiratory
chain perturbations reﬂects the complex interactions between the
inner and outer membranes. The core of the respiratory chain and
oxidative phosphorylation pathway is composed of ﬁve multisubunit
complexes (I-V) located within the mitochondrial inner membrane
(MIM). In addition to mutations in mitochondrial DNA-encoded
proteins, tRNAs and ribosomal RNAs, mutations in nuclear genes not
directly related to oxidative phosphorylation, such as assembly
factors, chaperones, and enzymes of phospholipid metabolism, have
emerged as potential causes of mitochondrial respiratory chain
disorders. These defects leading to secondary loss in oxidative
function have been referred to as class II respiratory chain defects
(reviewed in [48–51]). While the absence of VDAC1 leads to a
reduction in multiple respiratory chain enzymatic activities in both
the heart and the gastrocnemius, the absence of VDAC3 is only
associated with complex IV deﬁciency in the heart and no detectable
deﬁciency in the gastrocnemius. Since these deﬁciencies are observed
in both intact and frozen mitochondrial samples, a failure to conduct
metabolites across the MOM cannot explain these observations.
Therefore, there is a structural dependence between VDAC and
different respiratory enzyme complexes. Complex IV (COX), the
terminal enzyme in the mitochondrial respiratory chain, is composed
of 13 subunits, 10 of which are encoded by nuclear genes. The three
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Fig. 5. Expression analysis of COXIV subunit. Western blot corresponding to the sample
homogenates from wild type (Wt), vdac1−/− and vdac3−/− heart was probed with an
antibody speciﬁc for COXIV subunit. Cytochrome c was used for loading control.
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core of the enzyme. The details of the assembly of complex IV are still
poorly understood. In a subset of patients with Leigh Syndrome, an
early onset, fatal neurodegenerative disorder, COX activity is reduced
to 10–25% of control levels. Mutations in SURF1, a nuclear gene
involved in COX assembly, have been reported in some Leigh
Syndrome patients [52,53]. Whether the same mechanism is at play
in VDAC deﬁcient muscles, or whether there is a defect in subunit
import into mitochondria is the subject of ongoing studies. Prelim-
inary data with a western blot analysis using COXIV speciﬁc antibody
does not show any alteration in the amount of this subunit in VDAC
deﬁcient hearts (Fig. 5).
5. Conclusions
In conclusion, we present evidence that unlike VDAC1, VDAC3
fulﬁlls different functions in two types of striated muscles. We also
show that VDACs functionally interact with theMIM as evidenced by a
reduction in respiratory chain activities. Although the nature of this
interaction is at present unknown, VDAC deﬁcient mice provide a
model for class II respiratory chain defects and therefore can be used
to dissect some of the molecular mechanisms underlying respiratory
chain defects observed in mitochondrial diseases.
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